vs
Side-by-side financial comparison of CF BANKSHARES INC. (CFBK) and FONAR CORP (FONR). Click either name above to swap in a different company.
FONAR CORP is the larger business by last-quarter revenue ($25.5M vs $15.7M, roughly 1.6× CF BANKSHARES INC.). CF BANKSHARES INC. runs the higher net margin — 40.0% vs 8.0%, a 32.0% gap on every dollar of revenue. On growth, CF BANKSHARES INC. posted the faster year-over-year revenue change (12.6% vs 2.4%). CF BANKSHARES INC. produced more free cash flow last quarter ($18.2M vs $-227.0K). Over the past eight quarters, CF BANKSHARES INC.'s revenue compounded faster (13.7% CAGR vs -0.3%).
CF Bankshares Inc. is a U.S.-based regional bank holding company operating through its community bank subsidiary. It offers a full suite of personal and commercial banking solutions including deposit products, various loan options, wealth management services and digital banking tools, primarily serving individual consumers and small-to-medium business clients across the U.S. Midwest region.
FONAR Corp is a specialized medical technology firm that designs, manufactures, and distributes innovative MRI systems including upright and open models. It primarily serves U.S. hospitals, diagnostic imaging centers, and healthcare providers, delivering high-precision scanning solutions for clinical diagnostic use.
CFBK vs FONR — Head-to-Head
Income Statement — Q4 FY2025 vs Q2 FY2026
| Metric | | |
|---|---|---|
| Revenue | $15.7M | $25.5M |
| Net Profit | $5.7M | $2.1M |
| Gross Margin | — | — |
| Operating Margin | 43.4% | 13.5% |
| Net Margin | 40.0% | 8.0% |
| Revenue YoY | 12.6% | 2.4% |
| Net Profit YoY | 29.9% | 4.7% |
| EPS (diluted) | $0.88 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $15.7M | $25.5M | ||
| Q3 25 | $15.5M | $26.0M | ||
| Q2 25 | $15.6M | $27.3M | ||
| Q1 25 | $14.1M | $27.2M | ||
| Q4 24 | $14.0M | $24.9M | ||
| Q3 24 | $13.1M | $25.0M | ||
| Q2 24 | $12.6M | $25.9M | ||
| Q1 24 | $12.2M | $25.7M |
| Q4 25 | $5.7M | $2.1M | ||
| Q3 25 | $2.3M | $2.3M | ||
| Q2 25 | $5.0M | $729.3K | ||
| Q1 25 | $4.4M | $2.5M | ||
| Q4 24 | $4.4M | $2.0M | ||
| Q3 24 | $4.2M | $3.1M | ||
| Q2 24 | $1.7M | $830.4K | ||
| Q1 24 | $3.1M | $1.9M |
| Q4 25 | 43.4% | 13.5% | ||
| Q3 25 | 17.5% | 14.1% | ||
| Q2 25 | 41.1% | 5.3% | ||
| Q1 25 | 39.5% | 15.2% | ||
| Q4 24 | 36.9% | 11.9% | ||
| Q3 24 | 40.4% | 21.0% | ||
| Q2 24 | 15.4% | 7.4% | ||
| Q1 24 | 30.9% | 16.8% |
| Q4 25 | 40.0% | 8.0% | ||
| Q3 25 | 15.1% | 8.7% | ||
| Q2 25 | 32.3% | 2.7% | ||
| Q1 25 | 31.4% | 9.2% | ||
| Q4 24 | 35.2% | 7.9% | ||
| Q3 24 | 32.2% | 12.6% | ||
| Q2 24 | 13.5% | 3.2% | ||
| Q1 24 | 25.2% | 7.3% |
| Q4 25 | $0.88 | — | ||
| Q3 25 | $0.36 | — | ||
| Q2 25 | $0.77 | — | ||
| Q1 25 | $0.68 | — | ||
| Q4 24 | $0.68 | — | ||
| Q3 24 | $0.65 | — | ||
| Q2 24 | $0.26 | — | ||
| Q1 24 | $0.47 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $259.0M | $121.0K |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $184.4M | $176.9M |
| Total Assets | $2.1B | $217.2M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $259.0M | $121.0K | ||
| Q3 25 | $272.4M | $122.0K | ||
| Q2 25 | $275.7M | $56.5M | ||
| Q1 25 | $241.0M | $123.0K | ||
| Q4 24 | $235.3M | $121.0K | ||
| Q3 24 | $233.5M | $136.0K | ||
| Q2 24 | $241.8M | $56.5M | ||
| Q1 24 | $236.9M | $134.0K |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | $66.9K | ||
| Q1 24 | — | — |
| Q4 25 | $184.4M | $176.9M | ||
| Q3 25 | $179.3M | $174.9M | ||
| Q2 25 | $177.0M | $172.6M | ||
| Q1 25 | $172.7M | $171.9M | ||
| Q4 24 | $168.4M | $169.8M | ||
| Q3 24 | $164.0M | $168.7M | ||
| Q2 24 | $159.6M | $166.0M | ||
| Q1 24 | $158.0M | $165.8M |
| Q4 25 | $2.1B | $217.2M | ||
| Q3 25 | $2.1B | $218.4M | ||
| Q2 25 | $2.1B | $216.9M | ||
| Q1 25 | $2.1B | $214.9M | ||
| Q4 24 | $2.1B | $208.0M | ||
| Q3 24 | $2.1B | $212.3M | ||
| Q2 24 | $2.0B | $214.2M | ||
| Q1 24 | $2.0B | $209.6M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 0.00× | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $18.7M | $171.0K |
| Free Cash FlowOCF − Capex | $18.2M | $-227.0K |
| FCF MarginFCF / Revenue | 115.6% | -0.9% |
| Capex IntensityCapex / Revenue | 3.1% | 1.6% |
| Cash ConversionOCF / Net Profit | 3.26× | 0.08× |
| TTM Free Cash FlowTrailing 4 quarters | $33.4M | $5.7M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $18.7M | $171.0K | ||
| Q3 25 | $5.5M | $1.7M | ||
| Q2 25 | $8.0M | $4.2M | ||
| Q1 25 | $2.2M | $3.1M | ||
| Q4 24 | $14.2M | $2.2M | ||
| Q3 24 | $-1.3M | $1.7M | ||
| Q2 24 | $4.0M | $4.6M | ||
| Q1 24 | $-1.2M | $2.8M |
| Q4 25 | $18.2M | $-227.0K | ||
| Q3 25 | $5.2M | $-177.0K | ||
| Q2 25 | $7.8M | $3.6M | ||
| Q1 25 | $2.2M | $2.6M | ||
| Q4 24 | $13.9M | $1.5M | ||
| Q3 24 | $-1.3M | $-148.0K | ||
| Q2 24 | $4.0M | $4.2M | ||
| Q1 24 | $-1.2M | $2.6M |
| Q4 25 | 115.6% | -0.9% | ||
| Q3 25 | 33.6% | -0.7% | ||
| Q2 25 | 50.3% | 13.1% | ||
| Q1 25 | 15.2% | 9.4% | ||
| Q4 24 | 99.6% | 6.0% | ||
| Q3 24 | -9.9% | -0.6% | ||
| Q2 24 | 31.6% | 16.1% | ||
| Q1 24 | -9.5% | 10.2% |
| Q4 25 | 3.1% | 1.6% | ||
| Q3 25 | 1.7% | 7.2% | ||
| Q2 25 | 0.7% | 2.4% | ||
| Q1 25 | 0.4% | 2.2% | ||
| Q4 24 | 1.9% | 3.0% | ||
| Q3 24 | 0.2% | 7.2% | ||
| Q2 24 | 0.1% | 1.6% | ||
| Q1 24 | 0.0% | 0.7% |
| Q4 25 | 3.26× | 0.08× | ||
| Q3 25 | 2.34× | 0.75× | ||
| Q2 25 | 1.58× | 5.79× | ||
| Q1 25 | 0.50× | 1.26× | ||
| Q4 24 | 3.21× | 1.14× | ||
| Q3 24 | -0.30× | 0.53× | ||
| Q2 24 | 2.35× | 5.54× | ||
| Q1 24 | -0.38× | 1.50× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CFBK
Segment breakdown not available.
FONR
| Managementof Diagnostic Imaging Centers | $23.2M | 91% |
| Manufacturingand Servicingof Medical Equipment | $2.4M | 9% |
